Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 27, 2019Ephedrine SulfateLack of assurance of sterility.US Compounding Inc · D-0508-2019Class IITerminatedFeb 27, 2019Divalproex Sodium Extended-release TabletsFailed Dissolution Specifications: Out of specification results observed for high dissolution.Dr. Reddy's Laboratories, Inc. · D-0507-2019Class IIITerminatedFeb 27, 2019Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testingMylan Pharmaceuticals Inc. · D-0506-2019Class IIOngoingFeb 27, 2019LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETSCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Torrent Pharma Inc. · D-0505-2019Class IIOngoingFeb 27, 2019LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETSCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Torrent Pharma Inc. · D-0504-2019Class IIOngoingFeb 27, 2019LOSARTAN POTASSIUM TABLETSCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Torrent Pharma Inc. · D-0503-2019Class IIOngoingFeb 27, 2019LOSARTAN POTASSIUM TABLETSCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Torrent Pharma Inc. · D-0502-2019Class IIOngoingFeb 27, 2019LOSARTAN POTASSIUM TABLETSCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Torrent Pharma Inc. · D-0501-2019Class IIITerminatedFeb 27, 2019Oxytocin 30 Units added to NS 500 mLSuperpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.Advanced Pharma Inc. · D-0499-2019Class IIITerminatedFeb 27, 2019Oxytocin 20 Units added to NS 1000 mLSuperpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.Advanced Pharma Inc. · D-0498-2019Class IIITerminatedFeb 27, 2019Oxytocin 10 Units added to NS 1000 mLSuperpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.Advanced Pharma Inc. · D-0497-2019Class IITerminatedFeb 27, 2019Fentanyl in 0.9% Sodium Chloride QS 0.5 mLLabeling: Incorrect expiration date.Advanced Pharma Inc. · D-0496-2019Class IITerminatedFeb 20, 2019MAGnesium 2 gm sulfateLabeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the...Avella of Deer Valley, Inc. Store 38 · D-1000-2019Class IITerminatedFeb 20, 2019MAGnesium 2gm sulfateLabeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the...Avella of Deer Valley, Inc. Store 38 · D-0999-2019Class IITerminatedFeb 20, 2019MAGnesium 1gm sulfateLabeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the...Avella of Deer Valley, Inc. Store 38 · D-0998-2019Class IITerminatedFeb 20, 2019Labetalol 20mgLabeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the...Avella of Deer Valley, Inc. Store 38 · D-0997-2019Class IIITerminatedFeb 20, 2019Esomeprazole Magnesium Delayed-Release Capsules USPDiscoloration: Esomeprazole Magnesium DR Capsules (40mg) may contain brown pellets.Dr. Reddy's Laboratories, Inc. · D-0995-2019Class IITerminatedFeb 20, 2019Infants' IbuprofenSuperpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.Tris Pharma Inc. · D-0495-2019Class IITerminatedFeb 20, 2019infants* IBUPROFENSuperpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.Tris Pharma Inc. · D-0494-2019Class IITerminatedFeb 20, 2019Infants' IbuprofenSuperpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.Tris Pharma Inc. · D-0493-2019Class IIITerminatedFeb 20, 2019Clobetasol Propionate Topical Solution USPDefective Container; complaints of leakage.Oxalis Labs · D-0492-2019Class IIITerminatedFeb 20, 2019Diltiazem HCl CD capsulesFailed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.Valeant Pharmaceuticals North America LLC · D-0491-2019Class IIITerminatedFeb 20, 2019Cardizem CDFailed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.Valeant Pharmaceuticals North America LLC · D-0490-2019Class IIITerminatedFeb 20, 2019Cardizem CDFailed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.Valeant Pharmaceuticals North America LLC · D-0489-2019Class IIITerminatedFeb 20, 2019Cardizem CDFailed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.Valeant Pharmaceuticals North America LLC · D-0488-2019Class IIITerminatedFeb 20, 2019Cardizem CDFailed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.Valeant Pharmaceuticals North America LLC · D-0487-2019Class IITerminatedFeb 20, 2019CIDOFOVIR DIHYDRATECGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.LGM Pharma LLC · D-0486-2019Class ITerminatedFeb 20, 2019Levetiracetam in 0.54 % Sodium Chloride Injection 1Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75%...Dr. Reddy's Laboratories, Inc. · D-0485-2019Class IIITerminatedFeb 20, 2019Moxifloxacin Ophthalmic Solution USPFailed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.Lupin Pharmaceuticals Inc. · D-0484-2019Class IIITerminatedFeb 20, 2019COSOPT Ophthalmic SolutionFailed Stability Specifications: out of specification results for opalescence at 7 month stability study.Akorn Inc · D-0483-2019Class IITerminatedFeb 20, 2019LET Gel 4%Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.US Compounding Inc · D-0482-2019Class IITerminatedFeb 20, 2019Folic AcidLack of sterility assurance.Promise Pharmacy, LLC · D-0481-2019Class IITerminatedFeb 20, 2019Zinc SulfateLack of sterility assurance.Promise Pharmacy, LLC · D-0480-2019Class IITerminatedFeb 20, 2019Glycyrrhizic AcidLack of sterility assurance.Promise Pharmacy, LLC · D-0479-2019Class IITerminatedFeb 20, 2019DexpanthenolLack of sterility assurance.Promise Pharmacy, LLC · D-0478-2019Class IITerminatedFeb 20, 2019Lysine HClLack of sterility assurance.Promise Pharmacy, LLC · D-0477-2019Class IITerminatedFeb 20, 2019Leucine/Isoleucine/Valine injectionLack of sterility assurance.Promise Pharmacy, LLC · D-0476-2019Class IITerminatedFeb 20, 2019Pyridoxine HClLack of sterility assurance.Promise Pharmacy, LLC · D-0475-2019Class IITerminatedFeb 20, 2019Procaine HClLack of sterility assurance.Promise Pharmacy, LLC · D-0474-2019Class IITerminatedFeb 20, 2019Trim CalmLack of sterility assurance.Promise Pharmacy, LLC · D-0473-2019